Investment
Features
FeesSafety
Academy
More
Pluang+

Gold holds steady despite rising US bond yields and Fed rate hike fears amid Middle East tensions.

Market News
15 Sep 2026
Kitco
View Source
Neutral
Gold holds steady despite rising US bond yields and Fed rate hike fears amid Middle East tensions.

Gold prices remain resilient near $4,295 an ounce despite strong selling pressure from rising US bond yields hitting two-decade highs. This is driven by expectations of a Federal Reserve rate hike to combat persistent inflation and geopolitical tensions in the Middle East pushing oil prices higher. Commerzbank notes that gold's relative strength may reflect market hedging against a potential clash between the Fed and the Trump administration, which has pressured the Fed to cut rates. While higher rates typically weigh on gold, the bank expects limited downside this year, forecasting gold around $4,500 an ounce by year-end, supported by skepticism of the US dollar and concerns over sovereign debt risks.

Gold price dynamics amid US interest rate tensions provide context for Pluang's market snapshot as of Sep 16, 2026 00:21 WIB: out of 150 US stocks, 44 rose and 106 fell. Among notable movers, Opendoor Technologies Inc dropped 5.20% to USD 2.65, Sea Limited declined 4.73% to USD 103.53, and Carvana Co fell 4.62% to USD 67.59. This contrasts with gold's resilience near $4,295 an ounce despite rising US bond yields and geopolitical risks.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App